2026 NPPES data Hematology & Oncology Physician NPI 1811314263 M.D.
Verify on CMS →

RITIKA VANKINA, M.D.

Hematology & Oncology Physician in FARMINGTON, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
275
Medicare Part D claims · 76 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
37%
generic claims · 63% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.3496/100
▼ 4 pts below national avg 83.1 · [object Object]

What the federal data shows

RITIKA VANKINA, M.D. reported a CMS MIPS final score of 79.3496/100 — below the 83.1 national average — and filed 275 Medicare Part D claims in 2023.

79.3496/100
MIPS score · -4 vs avg
275
Part D claims, 2023
37%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RITIKA VANKINA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 30th percentile higher than 30% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RITIKA VANKINA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RITIKA VANKINA, M.D.?

Near national average

NPI registry status

Active

Issued 03/24/2014

NPI 1811314263

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

275 68% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

79.3496/100 3.750399999999999% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Connecticut

How Hematology & Oncology Physician compares to other specialties among Connecticut providers

Connecticut providers

Hematology & Oncology Physician share within Connecticut

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Connecticut

Medicare quality performance — MIPS

RITIKA VANKINA, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
79.3496/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 79.3496/100 vs national avg 83.1

0%100%National avg83%79.3%
MIPS final score (Hematology & Oncology Physician) — 79.3496/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RITIKA VANKINA, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 263 FARMINGTON AVE, FARMINGTON, CT, 06030, with a listed phone of (860) 679-2000. NPI 1811314263 was issued on 03/24/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VANKINA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 275 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $701K in drug spend, split 63% brand-name and 37% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.3496/100 for the 2023 performance year (Quality 69.2231, Cost 48.0871), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

263 FARMINGTON AVE
FARMINGTON, CT 06030

Provider Details

NPI 1811314263
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 03/24/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.3496
Final Score
Avg: 83.1
69.2231
Quality
48.0871
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where RITIKA VANKINA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF CONNECTICUT HEALTH CENTER
FARMINGTON, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Brand-heavy

RITIKA VANKINA, M.D. — brand share 63.0%
Specialty average (est.)

63% brand-name claims vs 37% generic, on 275 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

275
Total Claims
$701K
Total Drug Cost
76
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
498
Total Day Supply
14,056
Brand vs Generic
63% brand / 37% generic
Brand Drug Cost
$598K
Generic Drug Cost
$102K

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
2.09
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RITIKA VANKINA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Eliquis
Apixaban
84
Xarelto
Rivaroxaban
59
Enoxaparin Sodium
21
Hydroxyurea
11
Warfarin Sodium
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How RITIKA VANKINA, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

RITIKA VANKINA, M.D.'s 275 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as VANKINA.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RITIKA VANKINA, M.D.'s specialty?
RITIKA VANKINA, M.D. specializes in Hematology & Oncology Physician and practices in FARMINGTON, Connecticut. Credentials: M.D..
How much does RITIKA VANKINA, M.D. prescribe under Medicare Part D?
In 2023, RITIKA VANKINA, M.D. wrote 275 Medicare Part D claims totaling $701K in drug costs for 76 beneficiaries.
What is RITIKA VANKINA, M.D.'s Medicare quality score?
RITIKA VANKINA, M.D. has a CMS MIPS Final Score of 79.3496/100 (Quality: 69.2231, Cost: 48.0871). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RITIKA VANKINA, M.D. located?
RITIKA VANKINA, M.D. is located at 263 FARMINGTON AVE, FARMINGTON, CT, 06030. Phone: (860) 679-2000.
What is RITIKA VANKINA, M.D.'s NPI number?
RITIKA VANKINA, M.D.'s National Provider Identifier (NPI) is 1811314263, issued on 03/24/2014.
Does RITIKA VANKINA, M.D. prescribe more brand-name or generic drugs?
RITIKA VANKINA, M.D.'s prescribing is 63% brand-name and 37% generic drugs by claim count, with $598K in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does RITIKA VANKINA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RITIKA VANKINA, M.D.'s most frequently prescribed drugs include Eliquis, Xarelto, Enoxaparin Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RITIKA VANKINA, M.D. accept Medicare?
RITIKA VANKINA, M.D. appears in CMS Medicare data with 275 Part D claims and 76 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RITIKA VANKINA, M.D.'s credentials?
RITIKA VANKINA, M.D.'s NPI is 1811314263 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology